Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers—results from the DELCODE study

BACKGROUND: Early identification of individuals at risk of dementia is mandatory to implement prevention strategies and design clinical trials that target early disease stages. Subjective cognitive decline (SCD) and neuropsychiatric symptoms (NPS) have been proposed as potential markers for early ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Sannemann, Lena, Schild, Ann-Katrin, Altenstein, Slawek, Bartels, Claudia, Brosseron, Frederic, Buerger, Katharina, Cosma, Nicoleta Carmen, Fliessbach, Klaus, Freiesleben, Silka Dawn, Glanz, Wenzel, Heneka, Michael T., Janowitz, Daniel, Kilimann, Ingo, Kobeleva, Xenia, Laske, Christoph, Metzger, Coraline D., Munk, Matthias H. J., Perneczky, Robert, Peters, Oliver, Polcher, Alexandra, Priller, Josef, Rauchmann, Boris, Rösch, Christina, Rudolph, Janna, Schneider, Anja, Spottke, Annika, Spruth, Eike Jakob, Teipel, Stefan, Vukovich, Ruth, Wagner, Michael, Wiltfang, Jens, Wolfsgruber, Steffen, Duezel, Emrah, Jessen, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566134/
https://www.ncbi.nlm.nih.gov/pubmed/33066827
http://dx.doi.org/10.1186/s13195-020-00701-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566134/
https://www.ncbi.nlm.nih.gov/pubmed/33066827
http://dx.doi.org/10.1186/s13195-020-00701-7

Ejemplares similares